Evidence map›Paper›PMID 17357049›Full record

Trial reportThe Journal of infectious diseases2007

Inhibition of rhinovirus replication in vitro and in vivo by acid-buffered saline.

James E Gern, Anne G Mosser, Cheri A Swenson, Paul J Rennie, R James England, Jacqueline Shaffer, Haruko Mizoguchi

Open access · bronzeAbstract readClinical TrialRandomized Controlled Trial
In one paragraph

Trial report in The Journal of infectious diseases, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 26 citations in OpenAlex.

  1. Nasal sprays and a behavioural intervention for respiratory tract infections in primary care: 12-month follow-up of a randomised open-label trial.The British journal of general practice : the journal of the Royal College of General Practitioners · 2026
    Trial
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. The common cold: potential for future prevention or cure.Current allergy and asthma reports · 2014
    Review
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

James E GernDivision of Allergy and Immunology, Department of Pediatrics, University of Wisconsin, Madison, WI 53792, USA. gern@medicine.wisc.edu
Anne G Mosser
Cheri A Swenson
Paul J Rennie
R James England
Jacqueline Shaffer
Haruko Mizoguchi
Procter & Gamble (United States) · USUniversity of Wisconsin–Madison · USHull Royal Infirmary · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Human rhinoviruses (HRVs) are quite sensitive to low pH. To determine whether this characteristic might be a therapeutic target, we evaluated the sensitivity of HRV to low-pH buffers in vitro and in vivo. Our findings confirm that low pH inhibited replication of most HRVs and reduced the replication of influenza virus. Preliminary experiments verified that the surface pH of the human nasopharynx could be transiently lowered to pH approximately 4.0 by topical administration of citrate/phosphate (CP) buffers, which was well tolerated. In a pilot experimental colds study, intranasal administration of CP buffer, compared with normal saline, reduced viral shedding by 1 log unit (10(3) vs. 10(4) 50% tissue culture infective dose/mL; P<.01), although respiratory symptoms were not significantly reduced. These findings demonstrate that low-pH buffers have antiviral activity in vivo and suggest that a larger clinical trial is warranted to determine whether this approach could reduce rates of viral transmission.

Indexed as

Administration, IntranasalAdolescentAdultBronchiBuffersCitric AcidCross-Over StudiesFemaleHeLa CellsHumansHydrogen-Ion ConcentrationMaleMiddle AgedNasopharynxNosePhosphatesBuffersCitric AcidPhosphatesSodium Chloride

Identifiers

PMID17357049
PMCPMC7110134
OpenAlexW1982146873

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.